159 related articles for article (PubMed ID: 17455343)
1. Analysis of known crystals to design polymorph prediction strategies.
Young PH; Ando HY
J Pharm Sci; 2007 May; 96(5):1203-36. PubMed ID: 17455343
[TBL] [Abstract][Full Text] [Related]
2. Insight to the thermodynamic stability of molecular crystals through crystallographic studies of a multipolymorph system.
Ng AT; Lai C; Dabros M; Gao Q
J Pharm Sci; 2014 Nov; 103(11):3423-3431. PubMed ID: 25252084
[TBL] [Abstract][Full Text] [Related]
3. Modeling the interplay of inter- and intramolecular hydrogen bonding in conformational polymorphs.
Karamertzanis PG; Day GM; Welch GW; Kendrick J; Leusen FJ; Neumann MA; Price SL
J Chem Phys; 2008 Jun; 128(24):244708. PubMed ID: 18601366
[TBL] [Abstract][Full Text] [Related]
4. Thermal expansion of organic crystals and precision of calculated crystal density: a survey of Cambridge Crystal Database.
Sun CC
J Pharm Sci; 2007 May; 96(5):1043-52. PubMed ID: 17455328
[TBL] [Abstract][Full Text] [Related]
5. The computational prediction of pharmaceutical crystal structures and polymorphism.
Price SL
Adv Drug Deliv Rev; 2004 Feb; 56(3):301-19. PubMed ID: 14962583
[TBL] [Abstract][Full Text] [Related]
6. Polymorph selection: the role of nucleation, crystal growth and molecular modeling.
Erdemir D; Lee AY; Myerson AS
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):746-55. PubMed ID: 17987526
[TBL] [Abstract][Full Text] [Related]
7. A third blind test of crystal structure prediction.
Day GM; Motherwell WD; Ammon HL; Boerrigter SX; Della Valle RG; Venuti E; Dzyabchenko A; Dunitz JD; Schweizer B; van Eijck BP; Erk P; Facelli JC; Bazterra VE; Ferraro MB; Hofmann DW; Leusen FJ; Liang C; Pantelides CC; Karamertzanis PG; Price SL; Lewis TC; Nowell H; Torrisi A; Scheraga HA; Arnautova YA; Schmidt MU; Verwer P
Acta Crystallogr B; 2005 Oct; 61(Pt 5):511-27. PubMed ID: 16186652
[TBL] [Abstract][Full Text] [Related]
8. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
[TBL] [Abstract][Full Text] [Related]
9. A strategy for predicting the crystal structures of flexible molecules: the polymorphism of phenobarbital.
Day GM; S Motherwell WD; Jones W
Phys Chem Chem Phys; 2007 Apr; 9(14):1693-704. PubMed ID: 17396181
[TBL] [Abstract][Full Text] [Related]
10. Conformational polymorphism in organic crystals.
Nangia A
Acc Chem Res; 2008 May; 41(5):595-604. PubMed ID: 18348538
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Force-Field Calculations of Lattice Energies on a Large Public Dataset, Assessment of Pharmaceutical Relevance, and Comparison to Density Functional Theory.
Marchese Robinson RL; Geatches D; Morris C; Mackenzie R; Maloney AGP; Roberts KJ; Moldovan A; Chow E; Pencheva K; Vatvani DRM
J Chem Inf Model; 2019 Nov; 59(11):4778-4792. PubMed ID: 31638394
[TBL] [Abstract][Full Text] [Related]
12. The polymorphism of progesterone: stabilization of a 'disappearing' polymorph by co-crystallization.
Lancaster RW; Karamertzanis PG; Hulme AT; Tocher DA; Lewis TC; Price SL
J Pharm Sci; 2007 Dec; 96(12):3419-31. PubMed ID: 17621678
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure prediction for cyclotrimethylene trinitramine (RDX) from first principles.
Podeszwa R; Rice BM; Szalewicz K
Phys Chem Chem Phys; 2009 Jul; 11(26):5512-8. PubMed ID: 19551222
[TBL] [Abstract][Full Text] [Related]
14. Successful prediction of a model pharmaceutical in the fifth blind test of crystal structure prediction.
Kazantsev AV; Karamertzanis PG; Adjiman CS; Pantelides CC; Price SL; Galek PT; Day GM; Cruz-Cabeza AJ
Int J Pharm; 2011 Oct; 418(2):168-78. PubMed ID: 21497184
[TBL] [Abstract][Full Text] [Related]
15. Knowledge-based model of hydrogen-bonding propensity in organic crystals.
Galek PT; Fábián L; Motherwell WD; Allen FH; Feeder N
Acta Crystallogr B; 2007 Oct; 63(Pt 5):768-82. PubMed ID: 17873446
[TBL] [Abstract][Full Text] [Related]
16. Validation of a search technique for crystal structure prediction of flexible molecules by application to piracetam.
Nowell H; Price SL
Acta Crystallogr B; 2005 Oct; 61(Pt 5):558-68. PubMed ID: 16186656
[TBL] [Abstract][Full Text] [Related]
17. Combined crystal structure prediction and high-pressure crystallization in rational pharmaceutical polymorph screening.
Neumann MA; van de Streek J; Fabbiani FP; Hidber P; Grassmann O
Nat Commun; 2015 Jul; 6():7793. PubMed ID: 26198974
[TBL] [Abstract][Full Text] [Related]
18. Development of a targeted polymorph screening approach for a complex polymorphic and highly solvating API.
Campeta AM; Chekal BP; Abramov YA; Meenan PA; Henson MJ; Shi B; Singer RA; Horspool KR
J Pharm Sci; 2010 Sep; 99(9):3874-86. PubMed ID: 20575000
[TBL] [Abstract][Full Text] [Related]
19. Computational studies of crystal structure and bonding.
Gavezzotti A
Top Curr Chem; 2012; 315():1-32. PubMed ID: 21506002
[TBL] [Abstract][Full Text] [Related]
20. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
Reutzel-Edens SM
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
